A phase II trial of paclitaxel in refrac
โ
Alan B. Sandler; Antonios Cristou; Susan Fox; Stephen D. Williams; Craig R. Nich
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 78 KB
๐ 2 views
over 24 hours every 21 days without growth factor support. The median age of the patients was 32.5 years (range, 18-49 years). The testis was the primary site of Genitourinary Oncology Program, Indiana Unitumor for 13 patients (72%) and the tumor was extragonadal in 5 patients (28%).